Early Lessons Learned After Our First Implantations of an Off-the-Shelf Single-Branch TEVAR

Clicks: 1
ID: 315765
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #347 of 432 articles by views in the british journal of surgery

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 432 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Background Thoracic endovascular aortic repair (TEVAR) involving the proximal descending thoracic aorta often requires coverage of the left subclavian artery (LSA), which may increase the risk of stroke or upper limb ischemia. Off-the-shelf single-branch TEVAR devices offer an alternative to surgical debranching or custom-made grafts, particularly in urgent settings. Aims To evaluate early clinical outcomes, technical feasibility, and intraoperative challenges during initial implantations of an off-the-shelf single-branch TEVAR device. Methods A retrospective single-center case series was conducted including consecutive patients treated with single-branch TEVAR between January and September 2025. Patient characteristics, procedural details, intraoperative events, and early postoperative outcomes were analyzed. Follow-up included in-hospital and three-month outcomes. Results Twelve patients were included (mean age 68 years) and 67% were female (Figure.1). Indications comprised thoracic aortic aneurysm (50%), aortic dissection (33%), intramural hematoma with aneurysm (8%), and penetrating aortic ulcer (8%) (Figure.2). Technical success was achieved in all cases. Mean procedure time was 110 minutes, and mean hospital stay was 7 days. Cerebrospinal fluid drainage was used in one third of patients. Two intraoperative device- or access-related complications occurred and were successfully managed endovascularly or surgically. Femoral access closure failure occurred in four patients and was treated with additional closure devices. One patient experienced a transient posterior stroke with complete neurological recovery, and one patient developed transient paraparesis following a secondary endovascular procedure. No reinterventions or 30-day mortality occurred. LSA branch patency was 100%, and three-month follow-up was uneventful apart from one minor access-site hematoma. Conclusion Early experience with off-the-shelf single-branch TEVAR demonstrates high technical success and favorable short-term outcomes. Immediate device availability represents a major advantage in urgent cases. Awareness of device-specific and access-related complications is essential during the initial learning phase. Further studies with longer follow-up are required to assess long-term durability and branch patency.For image description, please refer to the figure legend and surrounding text. For image description, please refer to the figure legend and surrounding text. For image description, please refer to the figure legend and surrounding text.
Reference Key
openalex_W7163405449 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors H Ceyran, E Mujagic
Journal the british journal of surgery
Year 2026
DOI
10.1093/bjs/znag055.069
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.